---
schema_version: "secwatch.filing_event.v1"
accession: "0001289848-21-000041"
form_type: "8-K"
ticker: "HURN"
cik: "0001289848"
company_name: "Huron Consulting Group Inc."
filed_at: "2021-11-02T23:59:59+00:00"
generated_at: "2026-06-28T14:57:31.501579+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Huron Q3 revenue up 9.1% to $224M; updates full-year guidance to $885-905M

## Summary
- Q3 net income from continuing ops rose 23.8% to $13.7M; diluted EPS $0.64 vs. $0.50 YoY.
- Adjusted diluted EPS from continuing ops increased 32.2% to $0.78, compared to $0.59 in Q3 2020.
- Full-year 2021 revenue guidance narrowed to $885M–$905M; management expects strong Q4 growth.
- Completed sale of Life Sciences business to Oliver Wyman on Nov 1, 2021; no significant impact on guidance.
- Digital, technology & analytics offerings comprised ~40% of total revenue through first nine months of 2021.

## SEC filing metadata
- accession: 0001289848-21-000041
- form_type: 8-K
- ticker: HURN
- cik: 0001289848
- company_name: Huron Consulting Group Inc.
- filed_at: 2021-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289848/000128984821000041/0001289848-21-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289848/000128984821000041/hurn-20211102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001289848-21-000041
- JSON: https://secwatch.observer/filing/0001289848-21-000041.json
- Plain text: https://secwatch.observer/filing/0001289848-21-000041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.